Eye to the Future in Adenomyosis Research
This article summarizes current perspectives on future directions for basic, translational, and clinical research into adenomyosis, a poorly understood gynecologic disorder with significant morbidity.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This article is a narrative review summarizing the current state and future directions of basic, translational, and clinical research on adenomyosis, a disorder associated with dysmenorrhea, pelvic pain, heavy menstrual bleeding, infertility, and adverse pregnancy outcomes. Across epidemiology, risk factors, pathogenesis, pathophysiology, diagnosis, and treatment, it highlights substantial knowledge gaps and synthesizes recent concepts drawn from prior studies and research priorities. A stated limitation is that the paper summarizes “current thoughts” across many domains rather than presenting new original data. This paper is centrally about adenomyosis research — it outlines future directions spanning mechanisms, diagnosis, and treatment.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (24)
- Adenomyosis and Endometrial Cancer: Literature Review via openalex
- Adenomyosis: Mechanisms and Pathogenesis via openalex
- Animal Models of Adenomyosis via openalex
- Classification and Reporting Systems for Adenomyosis via openalex
- Current and Future Medical Therapies for Adenomyosis via openalex
- Current and Future Surgical and Interventional Management Options for Adenomyosis via openalex
- Global Transcriptome Abnormalities of the Eutopic Endometrium From Women With Adenomyosis via openalex
- GnRH agonist improves pregnancy outcome in mice with induced adenomyosis by restoring endometrial receptivity via openalex
- Imaging Diagnosis of Adenomyosis via openalex
- Pathology and Pathogenesis of Adenomyosis via openalex
- Physiomimetic Models of Adenomyosis via openalex
- Research Priorities for Endometriosis: Recommendations From a Global Consortium of Investigators in Endometriosis via openalex
- Symptoms of Adenomyosis and Overlapping Diseases via openalex
- Systematic review and meta‐analysis of adverse pregnancy outcomes after uterine adenomyosis via openalex
- Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex
- Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy via openalex
- Value of ultrasound shear wave elastography in the diagnosis of adenomyosis via openalex
- Women with adenomyosis are at higher risks of endometrial and thyroid cancers: A population-based historical cohort study via openalex
- W2799713746 via openalex
- W6784371400 via openalex
- W6785445929 via openalex
- W2943472942 via openalex
- W6786004957 via openalex
- W2922267617 via openalex
Cited by (6)
- Endometrial receptive status in patients of reproductive age with diffuse and focal adenomyosis 2023
- Bromocriptine inhibits proliferation in the endometrium from women with adenomyosis 2023
- Medical Treatment of Adenomyosis 2022
- Pathophysiology, diagnosis, and management of endometriosis 2022
- (no title) 2022
- Impact of Uterine Adenomyosis on Pregnancy Outcomes in Women Undergoing In Vitro Fertilization Treated With a Long-Term Pituitary Downregulation Protocol 2021
Source provenance
- europepmc
- last seen: 2026-06-13T06:22:48.782012+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:21:30.380497+00:00